Bayer AG (BAYGn.DE)
* Bayer says Regorafenib from Bayer granted priority review in Japan for the second-line treatment of liver cancer Further company coverage:
COPENHAGEN Enzymes maker Novozymes will cut 198 jobs and invest more in emerging markets, it said on Wednesday, adding it could time take to recapture past growth rates amid uncertainty over U.S. renewable energy policy and the takeover of a key partner.
FRANKFURT Bayer and Monsanto said on Tuesday they would spend at least half of their agriculture research and development budget in the United States over the next six years, following a meeting with President-elect Donald Trump last week.
* Trump elicited spending pledges from several big companies (Adds details on Bayer and Monsanto's previous R&D spending plans)
FRANKFURT, Jan 17 A future combined Bayer and Monsanto expects to spend about $16 billion on research and development over the next six years with at least half of this investment made in the United States, the two companies said in a statement on Tuesday.
* Spokesman declines comment on Trump spokesman remarks re U.S. development spending, jobs Source text for Eikon: Further company coverage:
WASHINGTON Bayer AG has pledged to boost its investments in the United States amid its deal to buy U.S. seeds giant Monsanto, investing $8 billion in research and development and adding American jobs, U.S. President-elect Donald Trump's spokesman said on Tuesday.
WASHINGTON, Jan 17 Bayer AG has pledged to boost its investments in the United States amid its deal to buy U.S. seeds giant Monsanto, investing$8 billion in research and development and adding American jobs, U.S. President-elect Donald Trump's spokesman said on Tuesday.
Jan 12 The following bids, mergers, acquisitions and disposals were reported by 1100 GMT on Thursday:
FRANKFURT German drugs and pesticides maker Bayer , which will need regulatory approval for its $66 billion deal to buy U.S. seeds giant Monsanto , said company chief executives had a productive meeting with U.S. president-elect Donald Trump.